Search

Displaying results 7201 - 7210 of 10000 in total
  1. Drug

    Selnoflast

    go.drugbank.com/drugs/DB21522
    Investigational

    Selnoflast is a small molecule drug. The usage of the INN stem '-noflast' in the name indicates that Selnoflast is a inflammasome protein NLRP3 inhibitor. … Selnoflast is under investigation in clinical trial NCT05924243 (A Study to Investigate The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7486967 in Participants With Early Idiopathic

  2. Drug

    Brimarafenib

    go.drugbank.com/drugs/DB21706
    Investigational

    Brimarafenib is a small molecule drug. The usage of the INN stem '-rafenib' in the name indicates that Brimarafenib is a Raf (rapidly accelerated fibrosarcoma) kinase inhibitor. … Brimarafenib is under investigation in clinical trial NCT04249843 (Study of Safety, Pharmacokinetics, and Antitumor Activity of BGB-3245 in Participants with Advanced or Refractory Tumors).

  3. Drug

    ASF-1075

    go.drugbank.com/drugs/DB05727
    Experimental

  4. Drug

    EMD-1201081

    go.drugbank.com/drugs/DB06181
    Investigational

  5. Drug

    Repifermin

    go.drugbank.com/drugs/DB06434
    Experimental

  6. Drug

    Edifoligide

    go.drugbank.com/drugs/DB06556
    Investigational

  7. Drug

    PRX-08066

    go.drugbank.com/drugs/DB05607
    Investigational

    Synonyms: 5-((4-(6-CHLOROTHIENO(2,3-D)PYRIMIDINE-4-YLAMINO)PIPERIDIN-1-YL)METHYL)-2-FLUOROBENZONITRILE MONOFUMURATE, 5-((4-(6-chlorothieno[2,3-d]pyrimidine-4-ylamino)piperidin-1-yl)methyl)-2-fluorobenzonitrile monofumurate
  8. Drug

    Regrelor

    go.drugbank.com/drugs/DB05553
    Investigational

  9. Drug

    Amcasertib

    go.drugbank.com/drugs/DB14866
    Investigational

    Amcasertib is under investigation in clinical trial NCT02483247 (A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer).

  10. Drug

    APG-1387

    go.drugbank.com/drugs/DB16095
    Investigational

    APG-1387 is under investigation in clinical trial NCT04568265 (A Clinical Study of APG-1387 in Combination With Entecavir in Patients With Chronic Hepatitis B).